BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 29502031)

  • 1. Multiscale deep neural network based analysis of FDG-PET images for the early diagnosis of Alzheimer's disease.
    Lu D; Popuri K; Ding GW; Balachandar R; Beg MF;
    Med Image Anal; 2018 May; 46():26-34. PubMed ID: 29502031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer's Disease using structural MR and FDG-PET images.
    Lu D; Popuri K; Ding GW; Balachandar R; Beg MF;
    Sci Rep; 2018 Apr; 8(1):5697. PubMed ID: 29632364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
    Chiba Y; Iseki E; Fujishiro H; Ota K; Kasanuki K; Suzuki M; Hirayasu Y; Arai H; Sato K
    Psychiatry Res Neuroimaging; 2016 Mar; 249():105-12. PubMed ID: 26857415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Alzheimer Disease From Mild Cognitive Impairment With a Deep Belief Network Based on 18F-FDG-PET Images.
    Shen T; Jiang J; Lu J; Wang M; Zuo C; Yu Z; Yan Z
    Mol Imaging; 2019; 18():1536012119877285. PubMed ID: 31552787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep learning based diagnosis of Alzheimer's disease using FDG-PET images.
    Kishore N; Goel N
    Neurosci Lett; 2023 Nov; 817():137530. PubMed ID: 37858874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
    Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
    J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.
    Mosconi L
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):486-510. PubMed ID: 15747152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Modality Cascaded Convolutional Neural Networks for Alzheimer's Disease Diagnosis.
    Liu M; Cheng D; Wang K; Wang Y;
    Neuroinformatics; 2018 Oct; 16(3-4):295-308. PubMed ID: 29572601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET.
    Etminani K; Soliman A; Davidsson A; Chang JR; Martínez-Sanchis B; Byttner S; Camacho V; Bauckneht M; Stegeran R; Ressner M; Agudelo-Cifuentes M; Chincarini A; Brendel M; Rominger A; Bruffaerts R; Vandenberghe R; Kramberger MG; Trost M; Nicastro N; Frisoni GB; Lemstra AW; van Berckel BNM; Pilotto A; Padovani A; Morbelli S; Aarsland D; Nobili F; Garibotto V; Ochoa-Figueroa M
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):563-584. PubMed ID: 34328531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
    Iaccarino L; Chiotis K; Alongi P; Almkvist O; Wall A; Cerami C; Bettinardi V; Gianolli L; Nordberg A; Perani D
    J Alzheimers Dis; 2017; 59(2):603-614. PubMed ID: 28671117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging.
    Choi H; Jin KH;
    Behav Brain Res; 2018 May; 344():103-109. PubMed ID: 29454006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-View Separable Pyramid Network for AD Prediction at MCI Stage by
    Pan X; Phan TL; Adel M; Fossati C; Gaidon T; Wojak J; Guedj E
    IEEE Trans Med Imaging; 2021 Jan; 40(1):81-92. PubMed ID: 32894711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
    Morbelli S; Bauckneht M; Arnaldi D; Picco A; Pardini M; Brugnolo A; Buschiazzo A; Pagani M; Girtler N; Nieri A; Chincarini A; De Carli F; Sambuceti G; Nobili F
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2073-2083. PubMed ID: 28785843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (18)F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease.
    Mosconi L; Tsui WH; Pupi A; De Santi S; Drzezga A; Minoshima S; de Leon MJ
    J Nucl Med; 2007 Jul; 48(7):1129-34. PubMed ID: 17574982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of GNN and MLP based machine learning for the diagnosis of Alzheimer's Disease involving data synthesis.
    Chen K; Weng Y; Hosseini AA; Dening T; Zuo G; Zhang Y
    Neural Netw; 2024 Jan; 169():442-452. PubMed ID: 37939533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG-PET for Prediction of AD Dementia in Mild Cognitive Impairment. A Review of the State of the Art with Particular Emphasis on the Comparison with Other Neuroimaging Modalities (MRI and Perfusion SPECT).
    Sanchez-Catasus CA; Stormezand GN; van Laar PJ; De Deyn PP; Sanchez MA; Dierckx RA
    Curr Alzheimer Res; 2017; 14(2):127-142. PubMed ID: 27357645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression.
    Chen X; Zhou Y; Wang R; Cao H; Reid S; Gao R; Han D;
    PLoS One; 2016; 11(5):e0154406. PubMed ID: 27183116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early identification of MCI converting to AD: a FDG PET study.
    Pagani M; Nobili F; Morbelli S; Arnaldi D; Giuliani A; Öberg J; Girtler N; Brugnolo A; Picco A; Bauckneht M; Piva R; Chincarini A; Sambuceti G; Jonsson C; De Carli F
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2042-2052. PubMed ID: 28664464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.